Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Ebiomedicine
|
June 25, 2026
A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours
Herui Yao, Ruihua Zhao, Xiuping Lai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 3, 2021
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Sunzhi Lin, Shuitu Feng, et al.
Technology in Cancer Research & Treatment
|
February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol
Jinjie He, Yue Liu, Chengcheng Liu, et al.
The Oncologist
|
January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu, Kun Wang, Meijin Huang, et al.
Experimental Hematology & Oncology
|
November 22, 2025
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors
Rongrui Liu, Rongbo Lin, Ning Li, et al.
Nature Communications
|
January 16, 2026
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial
Chuntao Gao, Yanqiao Zhang, Xiujuan Qu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Lang He, Mingqian Lu, et al.
Nature Medicine
|
June 1, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
Zhi Peng, Tianshu Liu, Hua Wang, et al.
Thoracic Cancer
|
September 20, 2022
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Chunwei Xu, Lu Si, Wenxian Wang, et al.
Global Medical Genetics
|
February 28, 2024
Expert Consensus on the Diagnosis and Treatment of <i>NRG1/2</i> Gene Fusion Solid Tumors
Chunwei Xu, Qian Wang, Dong Wang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Ebiomedicine
|
June 25, 2026
A multi-centre, phase 1a/1b dose escalation and expansion study of the HER2-directed antibody-drug conjugate T-Bren (BL-M07D1) in advanced breast cancer and other solid tumours
Herui Yao, Ruihua Zhao, Xiuping Lai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 3, 2021
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Sunzhi Lin, Shuitu Feng, et al.
Technology in Cancer Research & Treatment
|
February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol
Jinjie He, Yue Liu, Chengcheng Liu, et al.
The Oncologist
|
January 5, 2021
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial
Huabin Hu, Kun Wang, Meijin Huang, et al.
Experimental Hematology & Oncology
|
November 22, 2025
Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors
Rongrui Liu, Rongbo Lin, Ning Li, et al.
Nature Communications
|
January 16, 2026
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial
Chuntao Gao, Yanqiao Zhang, Xiujuan Qu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Lang He, Mingqian Lu, et al.
Nature Medicine
|
June 1, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
Zhi Peng, Tianshu Liu, Hua Wang, et al.
Thoracic Cancer
|
September 20, 2022
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Chunwei Xu, Lu Si, Wenxian Wang, et al.
Global Medical Genetics
|
February 28, 2024
Expert Consensus on the Diagnosis and Treatment of <i>NRG1/2</i> Gene Fusion Solid Tumors
Chunwei Xu, Qian Wang, Dong Wang, et al.
Page
of 5